Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertrophy, Left Ventricular | 3 | 2011 | 45 | 0.680 |
Why?
|
| Heart Failure | 4 | 2007 | 235 | 0.640 |
Why?
|
| Hypertension | 5 | 2011 | 796 | 0.630 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2004 | 85 | 0.420 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 1999 | 27 | 0.330 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 225 | 0.310 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2002 | 13 | 0.300 |
Why?
|
| Nitric Oxide Synthase | 2 | 2005 | 128 | 0.300 |
Why?
|
| Nitric Oxide | 2 | 2007 | 316 | 0.290 |
Why?
|
| Isosorbide Dinitrate | 1 | 2007 | 8 | 0.290 |
Why?
|
| Nitric Oxide Donors | 1 | 2007 | 18 | 0.290 |
Why?
|
| Stroke Volume | 3 | 2002 | 89 | 0.280 |
Why?
|
| Ventricular Remodeling | 1 | 2007 | 57 | 0.280 |
Why?
|
| Echocardiography, Doppler | 3 | 2002 | 37 | 0.260 |
Why?
|
| Echocardiography | 3 | 2011 | 144 | 0.200 |
Why?
|
| Cardiac Output | 1 | 1999 | 20 | 0.170 |
Why?
|
| Physical Exertion | 1 | 1999 | 26 | 0.170 |
Why?
|
| Blood Pressure | 3 | 2011 | 646 | 0.170 |
Why?
|
| Ventricular Function, Left | 1 | 1999 | 96 | 0.160 |
Why?
|
| Coronary Angiography | 2 | 2011 | 90 | 0.160 |
Why?
|
| Myocardial Ischemia | 1 | 1999 | 75 | 0.160 |
Why?
|
| Heart Ventricles | 1 | 1998 | 110 | 0.150 |
Why?
|
| Exercise | 1 | 2002 | 613 | 0.140 |
Why?
|
| Middle Aged | 10 | 2011 | 10129 | 0.140 |
Why?
|
| Aged | 7 | 2011 | 6741 | 0.140 |
Why?
|
| Male | 11 | 2011 | 20025 | 0.120 |
Why?
|
| Diastole | 3 | 2004 | 42 | 0.120 |
Why?
|
| Systole | 3 | 2004 | 61 | 0.110 |
Why?
|
| Endothelium, Vascular | 2 | 2005 | 237 | 0.110 |
Why?
|
| Risk Factors | 4 | 2011 | 3562 | 0.110 |
Why?
|
| Female | 10 | 2011 | 20969 | 0.100 |
Why?
|
| Humans | 14 | 2011 | 37093 | 0.100 |
Why?
|
| Adult | 7 | 2011 | 11712 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2011 | 2026 | 0.100 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 583 | 0.100 |
Why?
|
| Exercise Test | 2 | 2002 | 67 | 0.090 |
Why?
|
| Chest Pain | 1 | 2011 | 37 | 0.090 |
Why?
|
| Coronary Vessels | 1 | 2011 | 85 | 0.090 |
Why?
|
| Electrocardiography | 1 | 2011 | 156 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2005 | 67 | 0.080 |
Why?
|
| Superoxides | 1 | 2007 | 53 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 2379 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 227 | 0.070 |
Why?
|
| Coronary Artery Disease | 2 | 2005 | 142 | 0.070 |
Why?
|
| Registries | 2 | 2005 | 335 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2007 | 268 | 0.070 |
Why?
|
| Simvastatin | 1 | 2005 | 29 | 0.060 |
Why?
|
| Coronary Circulation | 1 | 2005 | 27 | 0.060 |
Why?
|
| Dyslipidemias | 1 | 2005 | 43 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2005 | 628 | 0.060 |
Why?
|
| Alleles | 1 | 2005 | 321 | 0.060 |
Why?
|
| Confidence Intervals | 2 | 2005 | 149 | 0.060 |
Why?
|
| Blood Flow Velocity | 2 | 2004 | 61 | 0.060 |
Why?
|
| Education, Medical | 1 | 2005 | 104 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 448 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2005 | 233 | 0.060 |
Why?
|
| Cooperative Behavior | 1 | 2005 | 219 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2005 | 198 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2002 | 91 | 0.050 |
Why?
|
| Cardiovascular Diseases | 2 | 2006 | 664 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 276 | 0.050 |
Why?
|
| Prognosis | 2 | 2005 | 739 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 767 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2005 | 560 | 0.040 |
Why?
|
| Gated Blood-Pool Imaging | 1 | 1999 | 2 | 0.040 |
Why?
|
| Cardiac Output, Low | 1 | 1999 | 2 | 0.040 |
Why?
|
| Exercise Tolerance | 1 | 1999 | 15 | 0.040 |
Why?
|
| Rest | 1 | 1999 | 26 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 935 | 0.040 |
Why?
|
| Death | 1 | 1998 | 8 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 1998 | 42 | 0.040 |
Why?
|
| Regression Analysis | 1 | 1999 | 455 | 0.040 |
Why?
|
| Survival Rate | 1 | 1998 | 311 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 1999 | 550 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 1999 | 225 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 1998 | 974 | 0.030 |
Why?
|
| Risk Assessment | 1 | 1998 | 753 | 0.030 |
Why?
|
| Georgia | 2 | 2005 | 174 | 0.030 |
Why?
|
| Comorbidity | 2 | 2005 | 623 | 0.030 |
Why?
|
| Primary Health Care | 2 | 2005 | 294 | 0.030 |
Why?
|
| Medical Audit | 1 | 2006 | 25 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2005 | 36 | 0.020 |
Why?
|
| Internal Medicine | 1 | 2005 | 24 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 68 | 0.020 |
Why?
|
| Group Practice | 1 | 2005 | 8 | 0.020 |
Why?
|
| Age Distribution | 1 | 2005 | 225 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2005 | 215 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2005 | 75 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2005 | 100 | 0.010 |
Why?
|
| Vasodilation | 1 | 2004 | 65 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 117 | 0.010 |
Why?
|
| Community Networks | 1 | 2005 | 108 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2004 | 195 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2005 | 125 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 191 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2005 | 134 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2005 | 138 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2005 | 215 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2005 | 534 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 191 | 0.010 |
Why?
|
| Community Health Services | 1 | 2005 | 185 | 0.010 |
Why?
|
| Curriculum | 1 | 2005 | 265 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 610 | 0.010 |
Why?
|
| Logistic Models | 1 | 2005 | 923 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 284 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 730 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 1369 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2005 | 519 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 1455 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 2000 | 10 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2000 | 20 | 0.010 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2000 | 19 | 0.010 |
Why?
|
| Mitral Valve | 1 | 2000 | 19 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2005 | 485 | 0.010 |
Why?
|
| Minority Groups | 1 | 2005 | 596 | 0.010 |
Why?
|
| Diet | 1 | 2005 | 801 | 0.010 |
Why?
|
| Smoking | 1 | 2005 | 940 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2005 | 2721 | 0.010 |
Why?
|
| Adolescent | 1 | 2004 | 5363 | 0.010 |
Why?
|